{"id":2262,"date":"2021-12-14T19:56:37","date_gmt":"2021-12-14T18:56:37","guid":{"rendered":"http:\/\/oncngs.eu\/?page_id=2262"},"modified":"2024-03-29T11:10:56","modified_gmt":"2024-03-29T10:10:56","slug":"call-for-tenders","status":"publish","type":"page","link":"https:\/\/oncngs.eu\/index.php\/call-for-tenders\/","title":{"rendered":"Call for tenders"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]<\/p>\n<p style=\"font-family: Rubik; color: black;\">The oncNGS consortium challenges the market to research and develop novel affordable solutions to provide the best NGS tests, for all solid tumour\/lymphoma patients.<\/p>\n<h3>The oncNGS call for tenders is open!<\/h3>\n<ul>\n<li><span style=\"font-size: 16px;\">The contract notice of the Pre-commercial procurement has been published at TED (Tenders Electronic Daily), the online version of the \u2018Supplement to the Official Journal\u2019 of the European Union dedicated to European public procurement <a href=\"https:\/\/ted.europa.eu\/udl?uri=TED:NOTICE:385103-2022:TEXT:FR:HTML\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>here<\/strong><\/a>.<\/span><\/li>\n<li><span style=\"font-size: 16px;\">The complete tender documentation is available <strong><a href=\"https:\/\/www.publicprocurement.be\/publication-workspaces\/01d6c98d-b358-4b0f-909d-b311188586c0\/documents\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a><\/strong>.<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Find help and guidelines on how to use the e-tendering platform <a href=\"https:\/\/www.publicprocurement.be\/sites\/default\/files\/documents\/chl_eten_submittender_en_20190709_100_0.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>here<\/strong><\/a>.<\/span><\/li>\n<li><span style=\"font-size: 16px;\"><strong>Deadline for submission: 17\/10\/2022!<\/strong><\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>Frequently asked questions:<\/h3>\n<div class=\"post-info-wrap\">\n<div class=\"post-info\">\n<ul>\n<li><span style=\"font-size: 16px;\">A FAQ page has been opened <a href=\"https:\/\/oncngs.eu\/wp-content\/uploads\/2022\/01\/FREQUENTLY-ASKED-QUESTIONS.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>. The summary of all questions and answers is presented anonymously and it will be regularly updated if we receive additional questions. The questions and clarifications related to the call for tender can be submitted in English through our <\/span><a href=\"https:\/\/oncngs.eu\/#contact\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: 16px;\">contact form.<\/span><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<\/div>\n<h3>Matchmaking page:<\/h3>\n<div class=\"post-info-wrap\">\n<div class=\"post-info\">\n<ul>\n<li><span style=\"font-size: 16px;\">We encourage companies that cannot cover the whole oncNGS PCP solution to team up with other companies. <a href=\"https:\/\/oncngs.eu\/index.php\/home\/matchmaking-find-a-partner\/\" target=\"_blank\" rel=\"noopener noreferrer\">The following suppliers<\/a> are currently interested in finding partners to create consortia and participate in the oncNGS PCP. Have a look to check if they complement your profile and get in touch with them using the given contact details. If you want to appear on the list, please contact us through our <a href=\"https:\/\/oncngs.eu\/#contact\" target=\"_blank\" rel=\"noopener noreferrer\">contact form<\/a> and provide us with the following information to be added on our matchmaking page:<\/span>\n<ul>\n<li><span style=\"font-size: 16px;\">Organisation name<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Website<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Contact person (name &amp; email address)<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Headquarter country<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Organisation size<\/span>\n<ul>\n<li><span style=\"font-size: 16px;\">Micro (&lt;10 employees)<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Small (&lt;50 employees)<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Medium (&lt;250 employees)<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Large<\/span><\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-size: 16px;\">Market presence (National\/European\/International)<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Overall description of you organisation (about 150 words)<\/span><\/li>\n<li><span style=\"font-size: 16px;\">Areas of cooperation sought<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"[vc_row][vc_column][vc_column_text] The oncNGS consortium challenges the market to research and develop novel affordable solutions to provide the best NGS tests, for all solid tumour\/lymphoma patients. The oncNGS call for tenders is open! The contract notice of the Pre-commercial procurement has been published at TED (Tenders Electronic Daily), the online version of the \u2018Supplement to the[&#8230;]","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/pages\/2262"}],"collection":[{"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/comments?post=2262"}],"version-history":[{"count":30,"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/pages\/2262\/revisions"}],"predecessor-version":[{"id":2283,"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/pages\/2262\/revisions\/2283"}],"wp:attachment":[{"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/media?parent=2262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}